Editorial: Hubachek on the Fallout from the CDC Opioid Prescribing Guidelines – Feb 2018 – Nina Luckman
Here’s the legal viewpoint from Worker’s Compensation lawyers:
The following editorial by local claimant attorney Gregory J. Hubachek and D. Kirkhoff Brainard addresses the Center for Disease Control’s (CDC) opioid prescribing guidelines and how they believe the guidelines’ scientific support is limited.
The CDC opioid prescribing guidelines provoked an immediate and sustained outcry from physicians and pain management specialists as soon as the draft version of the document was released to the public. Continue reading
Patient Advocacy Group Offers Opioid Prescribing Recommendations – June 13, 2018 – By Richard A. Lawhern, PhD and Steven E. Nadeau, MD
I’m proud that the advocacy group I’m involved with (ATIP) has its recommendations published in this mainstream medical magazine:
Advocacy group describes why CDC Guidelines on Opioid Prescribing should be withdrawn and rewritten.
In a whitepaper titled “Principles for Patient-Centered Opioid Prescription Guidelines,”* the Alliance for the Treatment of Intractable Pain [ATIP] argues that the CDC Guidelines for Prescribing Opioids for Chronic Pain “must be withdrawn and rewritten” to recognize both the indispensable role that opioids play in chronic pain management, and the central role of physicians in assessing and prescribing medications as patients require. Continue reading
AMA Castigated for Rightly Opposing a National 3-Day Limit on Opioid Prescriptions | Jacob Sullum|May. 30, 2018
A bill sponsored by Sen. Rob Portman (R-Ohio) would impose a nationwide limit of three days on initial prescriptions of opioids for acute pain.
“People are dying around the country every single day because patients are being prescribed too many opioid pills at one time,” Portman’s spokesman tells The Daily Beast‘s Jackie Kucinich.
Here’s yet another politician ignorant and brainwashed to believe the crisis is caused by prescription opioids. Continue reading
Dr Bob Twillman Discusses Opioid Risk Assessment in Cancer Pain and New Opioid Policies – April 12, 2018 – Laura Joszt
Typically, cancer pain management is carved out of policies that try to restrict opioid prescribing in an effort to combat the opioid epidemic, but with more and more patients surviving their cancer, there is some uncertainty regarding who is affected by these policies, explained Bob Twillman, PhD, executive director for the Academy of Integrative Pain Management.
The American Journal of Managed Care® (AJMC®):
How does pain management with cancer maybe differ from pain management in patients with other diseases? Continue reading
Two Midcoast business owners notify state of intent to sue over opioid taper rule – Author: Chris Facchini – March 28, 2017
Two Midcoast business owners, who are taking opioids to deal with chronic pain, have put the state on notice as they plan to sue over new rules that are forcing them to taper down their daily doses.
Mellor recently filed a notice of claim informing DHHS Commissioner Mary Mayhew of his clients intent to sue over a state rule that went into effect in January requiring people taking opioid pain medications to taper their doses down to no more than 100 morphine milligram equivalents (MME) per day,
How awful, this indifferent cruelty of the politicians in the legislature that voted this atrocity into law.
I never imagined my medical care would be legislated by vote-greedy politicians utterly ignorant of medicine, pain management, or even science in general. Continue reading
AAPM’s Advice for Evidence-Based Opioid Prescribing Guidelines – By Angie Drakulich – April 2018
I have mixed feelings about the big national pain organizations, like AAPM and the American Pain Foundation. I suspect there’s a lot of self-interest in making sure they get funds for their own offices and “management” of the organization.
While they are ostensibly fighting for pain patients, they put me off with their very glitzy “conferences” that brag about what a great location they are in and how luxurious the venue is. They advertise on Twitter almost year-round.
The Alliance for Treatment of Intractable Pain (ATIP) is the only one I know that doesn’t ask for money, just people’s time and effort. Continue reading
Canadian Guidance on opioid tapering in the context of chronic pain: Evidence, practical advice and frequently asked questions – free full-text PMC article /PMC5843113/ – Can Pharm J (Ott). 2018 Mar-Apr
Though this guideline is Canadian, it is modeled after the disastrous and unscientific opioid prescribing guidelines from the CDC, which are causing great harm to pain patients.
Throughout this document, I see no “evidence” presented for tapering functioning patients off opioids in the first place.
The 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain suggests opioid tapering should be considered for adults with chronic noncancer pain on ≥90 mg morphine equivalent dose daily.
This article assumes dose reductions must happen, that all patients *must* be tapered down below 90MME, even though the guidelines only “suggest” it. Continue reading
CDC 90MME Limit Does Not Apply to Chronic Pain Patients– medium.com – ThomasKlineMD
Dr. Kline reminds us that these guidelines weren’t intended for chronic pain patients, but rather for patients just now starting a chronic pain journey through the medical industry.
Transcripts of CDC press conference on day of release of Guideline, March 15, 2016 12:30am
From the press release: “I’ll let Dr. Deb Houry who is the Director of The National Center for Injury Prevention And Control (the division of CDC responsible for Guideline) in which this work resides comment further. Dr. Houry. Continue reading
Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts – Pain Medicine; Dec 2017 – Mark Edmund Rose, BS, MA
This is a very long article that examines how we got where we are now, how the demonization of all opioids as public policy was cleverly engineered by anti-opioid activists.
It provides a detailed history of how the CDC guideline was conceived and written mainly by anti-opioid activists (PROP) and how all that led up to it was manipulated to create the guideline as a manifesto for the “war on pain patients”.
While highly consequential to patients with pain whose function and quality of life may benefit from opioid analgesics, current assumptions about prescription opioid analgesics, including their role in the ongoing opioid overdose epidemic, have not been scrutinized. Continue reading